Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00722748 · ClinicalTrials.gov registry record

Genomic Investigation of Cardiovascular Diseases

A clinical trial of Coronary Artery Disease and Atrial Fibrillation, sponsored by Scripps Translational Science Institute.

Active
Registry status
15,000
Enrollment target
1
Study location

NCT00722748 is a study of Coronary Artery Disease and Atrial Fibrillation that is active but no longer recruiting, run by Scripps Translational Science Institute. The registered enrollment target is 15,000 participants, above the 1,218-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (1132% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00722748, a study of Coronary Artery Disease and Atrial Fibrillation, is active but no longer recruiting, sponsored by Scripps Translational Science Institute.

ACTIVE NOT RECRUITING
Registry status
15,000 participants
Enrollment target
1
Study location

Study Summary

This proposal puts forward a research plan to initiate a genetic databank, henceforth referred to as The Genebank at Scripps Clinic Registry. This database will usher in genomic research at Scripps as we strive to stay at the forefront of cardiovascular research in the new century. Human subject donation allows for the creation of the proposed genebank.

Study Locations (1)

California

  • Scripps Health - La Jolla

Trial Details

FieldValue
Enrollment Target 15,000 participants
Start Date 2007-06
Est. Completion 2030-09

What the Registry Record Tells You About NCT00722748

The ClinicalTrials.gov registry entry for NCT00722748 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 15,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,218-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (1132% higher). The listed sponsor is Scripps Translational Science Institute, which has 41 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00722748 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00722748 about?

NCT00722748 is a clinical study titled "Genomic Investigation of Cardiovascular Diseases". This proposal puts forward a research plan to initiate a genetic databank, henceforth referred to as The Genebank at Scripps Clinic Registry. This database will usher in genomic research at Scripps as we strive to stay at the forefront of cardiovascular research in the new century. Human subject don...

What is the current status of trial NCT00722748?

This trial is currently active not recruiting. The enrollment target is 15,000 participants. The study started on 2007-06. Estimated completion is 2030-09.

What conditions does trial NCT00722748 study?

This clinical trial studies the following conditions: Coronary Artery Disease, Atrial Fibrillation, Myocardial Infarction, Aortic Stenosis, Mitral Regurgitation.

Who is sponsoring clinical trial NCT00722748?

This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00722748 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.